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Objectives. This study characterized the attenuation of myocar-
dial ischemia observed with re-exercise to determine whether: 1) a
differing exercise intensity modifies this attenuation; 2) it could be
explained by contractile down-regulation or stunning; 3) it is medi-
ated by activation of ATP-sensitive potassium channels (K1-ATP).
Background. Subjects with ischemic heart disease (IHD) fre-
quently note less angina with re-exercise after a brief rest. Potential
mechanisms of this ‘warm-up’ phenomenon have been little explored.
Methods. IHD subjects with a positive exercise test were
studied. Groups I and II (12 subjects each) underwent 2 succes-
sive Naughton protocol exercise echocardiography tests (with 1
min instead of 2 min stages for Group II). Group D (10 subjects)
had type II diabetes, were on >10 mg daily of the K1-ATP blocker,
glibenclamide, and underwent the group I exercise protocol. The
ischemic threshold or rate-pressure product at 1 mm ST segment
depression, ST depression corresponding to the peak rate-
pressure product of the first exercise (maximum ST depression
equivalent), and left ventricular wall motion indexes before and
immediately after each exercise were analyzed.
Results. Exercise-induced myocardial ischemia with re-exercise
was similarly attenuated in groups I, II, and D. The ischemic
threshold was raised by nearly 20% with re-exercise (p 5 0.001,
p 5 0.02, and p 5 0.02, respectively) and the maximum ST
depression equivalent was nearly halved on re-exercise (p 5 0.005,
p 5 0.006, and p 5 0.001, respectively). Exercise-induced wall
motion dysfunction was attenuated with re-exercise. In group I,
wall motion returned to the initial baseline score prior to exercise
2, whereas in the more intense protocol of group II, wall motion
dysfunction persisted prior to exercise 2.
Conclusions. Thus, the attenuation of myocardial ischemia
observed with re-exercise appears to be independent of the
intensity of the exercise protocol and is not explained by down-
regulation of myocardial contractility induced by the initial
ischemic stimulus. Since results were similar in diabetic subjects
on robust doses of glibenclamide, this phenomenon does not
appear to be mediated by K1-ATP activation.
(J Am Coll Cardiol 1998;32:1665–71)
©1998 by the American College of Cardiology
Subjects with chronic ischemic heart disease (IHD) frequently
describe the phenomenon of “warm-up” or “walk-through”
angina. They note that angina provoked by an initial exertion
is attenuated and even disappears if they momentarily diminish
or stop their exertion before resuming it. The initial exertion
appears to have acted as an ischemic conditioning stimulus.
This well-known clinical observation has been documented in
a number of studies using serial exercise testing or repetitive
cardiac pacing (1–10). Although re-exercise is associated with
an attenuation of ischemia, the heart rates and blood pressures
attained are the same or greater (3,5,7–10). The physiologic
basis of this phenomenon is unexplained and very few studies
have explored potential mechanisms. An increase in coronary
perfusion has been suggested (2,3,5,10,11) but never demon-
strated (4,6). Another hypothesis is an adaptive down-
regulation of regional myocardial contractile function in the
ischemic region, which diminishes ischemia by decreasing
oxygen demand (4,9,12,13). Because this latter possibility has
not been directly tested, we undertook this study in stable
angina subjects coupling serial treadmill exercise with echocar-
diography. We also sought to characterize the phenomenon of
exercise-induced ischemic attenuation as completely as possi-
ble electrocardiographically, using two exercise protocols that
differed in their rate of increase in intensity. Finally, to test
whether this phenomenon might be mediated by a metabolic
mechanism through activation of adenosine triphosphate–
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sensitive potassium channels (K1-ATP) on cardiac myocytes,
we also studied diabetic stable angina subjects taking robust
chronic doses of the oral hypoglycemic agent and K1-ATP
blocker glibenclamide.
Methods
Patient selection. We first studied 24 subjects with stable
Canadian Cardiovascular Society class 1 to 2 angina, a previous
positive exercise test (ET) ($1-mm ST-segment depression
[STD] 80 ms after the J point) and significant coronary artery
disease documented either angiographically ($70% coronary
artery stenosis) or with thallium myocardial perfusion imaging
(significant reversible hypoperfusion). In addition, these sub-
jects had to have a normal resting electrocardiogram (ECG;
minor T-wave abnormality permitted) and normal left ventric-
ular (LV) contractility. All subjects had previously passed
several reproducible ETs and were very familiar with this
procedure. Beta-adrenergic blocking agents and calcium chan-
nel antagonists were stopped 48 h and long-acting nitrates 12 h
prior to exercise testing. On the day of study, subjects were
instructed not to exercise and to avoid any unusual exertion;
they rested for at least 30 min before testing, which was always
undertaken in midafternoon at least 2 h postprandially. The
study protocol was approved by the hospital ethics committee
and written informed consent was obtained from all subjects.
Exercise protocol. Of the initial 24 subjects, the first 12
(group I) performed two successive Naughton protocol tread-
mill ETs (protocol I). To determine whether a more rapidly
progressive ET protocol would yield similar findings, the next
12 subjects (group II) performed a modified Naughton proto-
col with 1-min instead of 2-min stages (protocol II). Of the two
tests per subject, each was supervised in random order by one
of the same two cardiologists, who were always blinded to the
findings of the first test. Each subject was also kept unaware of
the rationale for the study, of the findings of the first test and
could not see the display screen during exercise. Subjects were
instructed to exercise to near maximum discomfort whether
this was angina, fatigue or dyspnea (score of 7 to 8 of 10 on a
visual scale). Other predefined indications for stopping exer-
cise were: a drop in systolic blood pressure .10 mm Hg, a
serious arrhythmia or the subject’s desire to stop. Tests were
performed on a Q65 treadmill linked to a Q4000 monitor
(Quinton Instrument Co., Seattle, Washington). The ECG was
continuously monitored. Precordial leads V4, V5 and occasion-
ally V6 were positioned 6 to 8 cm lower than usual to permit
optimal echocardiographic imaging. A standard 12-lead ECG
was taken in the resting left lateral decubitus position (because
this was the position during echocardiographic imaging) and
standing positions and then every 30 s during exercise and
recovery. Each time both an averaged and a raw data ECG
were obtained. The arterial blood pressure was taken with a
mercury sphygmomanometer every minute until peak exercise
and then three times during recovery. The second ET was
promptly undertaken once the following conditions were met:
1) second baseline resting echocardiographic imaging (begun
once the ST segment was within 0.5 mm of the initial baseline)
was completed; 2) the ST segment had returned to its initial
(isoelectric) baseline documented in the left lateral decubitus
position prior to the first test; and 3) the subject was willing to
re-exercise.
Exercise ECG analysis. The ET was considered positive at
first appearance of 1-mm STD 80 ms after the J point
compared with the resting ECG taken in the left lateral
decubitus position just prior to exercise. The raw data and
averaged tracings were examined for consistency, requiring
consecutive beats (three for the raw data and two for the
averaged tracings) with similar findings. The time of onset of
ET positivity and the corresponding heart rate–systolic blood
pressure product (RPP) or ischemic threshold were noted. The
time of onset of angina was noted. Maximum STD was noted
on raw data and averaged tracings taken just before the end of
exercise. All leads exhibiting the criteria of positivity at end
exercise were noted. The RPP at peak exercise was noted and
the maximum STD corresponding to this RPP on the first test
was compared with the STD on the second test corresponding
to this same RPP. This analysis could be done in most subjects
because the peak RPP on the second test generally equaled or
exceeded that of the first test. This parameter is subsequently
referred to as the “maximum STD equivalent.” Recovery time
was the time from the end of exercise to the final appearance
of 1-mm STD noted on the 12-lead ECG recovery tracings.
After all patients had been studied, their exercise ECG trac-
ings were analyzed blindly and independently by two examin-
ers, resolving differences by consensus. Only the evaluation of
the maximum STD equivalent was, of necessity, performed
after unblinding.
Echocardiographic protocol. Two-dimensional echocardi-
ography was performed by the same experienced technician
using a Hewlett-Packard Sonos (Andover, Massachusetts)
1000 or 2000 echocardiograph. Images were acquired in the
long axis, short axis and apical two- and four-chamber views,
and were digitized in the usual manner with a Microsonics
Image Vue (Mawah, New Jersey) analyzer if the Sonos 1000
was used or with the incorporated stress test module if the
Sonos 2000 was used. Four echocardiographic documents were
acquired from each subject: 1) initial baseline prior to the first
ET; 2) immediately on termination of the first ET; 3) second
baseline prior to the second exercise; and 4) immediately
following the second ET. Postexercise imaging was obtained
Abbreviations and Acronyms
ECG 5 electrocardiogram or electrocardiographic
ET 5 exercise test
IHD 5 ischemic heart disease
K1-ATP 5 adenosine triphosphate–sensitive potassium channel(s)
LV 5 left ventricular
RPP 5 rate–pressure product
STD 5 ST-segment depression
VD 5 vessel disease
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within 90 s of the completion of exercise. Subjects were
rehearsed to promptly revert to the same left lateral decubitus
position on completion of each ET. Optimal echocardio-
graphic windows were determined for all subjects prior to the
first test. The LV wall motion score index (14) was determined
for each study independently by two experienced observers,
resolving their differences by consensus.
Study in diabetic subjects. We also studied 10 stable
angina subjects with type II diabetes mellitus (group D) who
were taking at least 10 mg daily of the oral hypoglycemic
sulfonylurea derivative glibenclamide and who had the same
eligibility criteria as groups I and II. These subjects under-
went serial exercise with protocol I, as group I, except that
echocardiography was not performed. They recovered fol-
lowing exercise in the same left lateral decubitus position.
Glibenclamide blood levels were measured at the time of
exercise testing.
Cross-over echocardiographic study. Because echocardio-
graphic findings differed in the two exercise protocols, to
ascertain whether this was due to the nature of the exercise
protocol or to differences in the patient groups, eight subjects
(four from the less intense and four from the more intense
exercise protocol) were subsequently restudied with cross-over
to the other exercise protocol with echocardiographic imaging
as described above. Inter-test exercise time was deliberately
identical in the two exercise protocols for each subject.
Statistical analysis. Means and SDs were determined for
continuous variables. Mean values of quantitative variables
were compared with one-way analysis of variance for unpaired
data when normality and variance assumptions were fulfilled
and with the Wilcoxon rank-sum test when they were not. A
posteriori comparisons were performed with Tukey’s method.
Mean values of quantitative variables were compared using
paired Student t tests for comparisons between the first and
second ETs. To measure relationships between variables,
Pearson product–moment correlation coefficients were used as
linear relationships were observed. All reported p values were
two-sided with results considered significant for p values
#0.05. Data were analyzed using the statistical package pro-
gram SAS (SAS Institute, Cary, North Carolina).
Results
Patient characteristics. Group I was comprised of 10 men
and 2 women aged 57 6 10 years and group II was comprised
of 11 men and 1 woman, aged 56 6 8 years. All 10 group D
subjects were men aged 65 6 6 years. Of the group I subjects,
11 had undergone coronary angiography within 1 year. Five
subjects had one-vessel disease (VD), five had two-VD and
one had three-VD. The remaining group I subject had a recent
scintigraphic study suggesting one-VD. All group II subjects
had undergone coronary angiography within the year. Three
subjects had one-VD, seven had two-VD and two had three-
VD. Seven group D subjects had a recent coronary arteriogram
showing one-VD in three subjects, two-VD in one and
three-VD in three. The remaining three group D subjects had
a scintigraphic study that was suggestive of one-VD in two
subjects and two-VD in one subject. Eight group D subjects
were on 10 mg glibenclamide daily and the remaining two
subjects on 20 mg daily. Glibenclamide serum level was 0.44 6
0.39 mmol/l (range 0.04 to 1.00) and values were unaccountably
skewed. Five subjects had serum levels #0.24 mmol/l and five
subjects had serum levels .0.60 mmol/l.
Exercise test results. The times between the end of ET 1
and the start of ET 2 for groups I, II and D were 13 6 4 min,
13 6 2 min and 13 6 3 min, respectively. For group I, RPP at
1-mm STD or the ischemic threshold was 18% higher in ET 2
and an increase was observed in 11 of the 12 subjects (p 5
0.001); for group II, it was 12% higher in ET 2 and an increase
was observed in 9 of the 12 subjects (p 5 0.02); for group D, it
was 16% higher in ET 2 and an increase in threshold was
observed in 8 of the 10 subjects (p 5 0.02) (Fig. 1). For group
I, the maximum STD equivalent of ET 2 (corresponding to the
peak RPP of ET 1) was 41% less than maximum STD that
occurred in ET 1; it was 2.2 6 0.6 mm in ET 1 and 1.3 6
1.0 mm in ET 2 (p 5 0.005). This parameter decreased in ET
2 in 9 of the 10 subjects in whom it could be measured. For
group II, the maximum STD equivalent decreased 39% in ET
2; it was 2.3 6 1.0 mm in ET 1 and 1.4 6 1.1 mm in ET 2 and
a decrease was noted in seven of the eight subjects in whom it
could be measured (p 5 0.006). For group D, the maximum
Figure 1. Ischemic thresholds (heart
rate 3 systolic blood pressure at
1-mm STD) in exercises (Ex) 1 and 2
are plotted for each subject in the
three study groups. Vertical bars dis-
play means and SDs.
1667JACC Vol. 32, No. 6 BOGATY ET AL.
November 15, 1998:1665–71 EXERCISE-INDUCED ISCHEMIC ATTENUATION
STD equivalent decreased 47%; it was 1.5 6 0.5 mm in ET 1
and 0.8 6 0.5 mm in ET 2 and a decrease occurred in all but
two subjects (p 5 0.001) (Fig. 2). Other ET results are shown
in Table 1. In ET 2 compared with ET 1, exercise time,
workload achieved metabolic equivalents (METS), time to
angina and time to 1-mm STD all increased and recovery time
decreased. The RPP at baseline was always higher prior to ET
2 and peak RPP was generally higher in ET 2.
The degree of attenuation of ischemic ECG indexes on
reexercise was not significantly different among the three
groups, and an analysis comparing the five group D subjects
with high range glibenclamide levels with the five subjects in
the low range did not indicate any differences in the changes
from ET 1 to ET 2.
Echocardiographic results. For group I, LV wall motion
score indexes are shown in the left panel of Figure 3 at the four
time points—prior to ET 1, just after ET 1, prior to ET 2 and
just after ET 2. In this group, ischemia-induced wall motion
dysfunction observed with the second exercise was significantly
attenuated compared with the dysfunction induced with the
first exercise (p 5 0.03). Importantly, wall motion returned to
initial baseline in 10 of 12 subjects prior to ET 2 in group I.
This appears to rule out stunning or contractile down-
regulation as the mechanism accounting for ischemic attenua-
tion with re-exercise. However, for group II, which had the
more intense exercise protocol, the findings were different
(right panel of Fig. 3): LV wall motion at baseline 2 did not
return to baseline 1 levels in 7 of 12 subjects; it was significantly
perturbed at baseline 2 compared with baseline 1 (p 5 0.002).
In addition, contrary to group I, wall motion dysfunction was
not significantly different in ET 2 compared with ET 1, perhaps
because of the added effect of persistent stunning contributing
to the dysfunction induced by ET 2. Nonetheless, the degree of
contractile dysfunction at ET 2 compared with baseline 2 was
less than that at ET 1 compared with baseline 1 (p 5 0.047),
suggesting that even in this more intense exercise protocol,
despite the added stunning effect, there was still an attenuation
of dysfunction on reexercise.
Cross-over study. To be certain that the persistent wall
motion dysfunction at baseline 2 in group II was due to the
intensity of the exercise protocol and not to patient character-
istics, a cross-over study of eight subjects was performed. Four
of these subjects came from the original, less intense protocol
I and all had a normal baseline 2 wall motion score in protocol
I; the other four subjects came from the original, more intense
protocol II and all had an abnormal baseline 2 wall motion
score compared with baseline 1. With the less intense protocol,
wall motion score indexes at baselines 1 and 2 were similar
Table 1. Exercise Test Results of the Three Patient Groups
Group I Group II Group D
Ex 1 Ex 2 p Value Ex 1 Ex 2 p Value Ex 1 Ex 2 p Value
Exercise time (min) 14.6 6 5.4 15.9 6 5.5 0.001 8.3 6 2.9 9.2 6 2.6 , 0.001 11.8 6 4.6 13.2 6 3.5 0.045
METS 8.2 6 3.4 8.9 6 3.6 0.01 9.0 6 3.4 10.1 6 3.1 0.003 6.5 6 2.5 7.4 6 2.1 0.008
Resting RPP (31023) 11.7 6 3.1 13.9 6 2.8 0.01 10.2 6 3.1 11.5 6 2.6 0.04 12.3 6 2.5 14.3 6 3.3 0.007
Peak RPP (31023) 22.1 6 4.0 23.7 6 3.7 0.046 23.1 6 4.2 24.9 6 5.3 0.07 23.3 6 4.4 26.2 6 5.2 0.006
Min to angina 9.4 6 5.9 12.3 6 5.7 , 0.001 5.2 6 2.8 6.9 6 4.0 0.02 6.9 6 3.3 9.0 6 4.1 0.04
Min to 1-mm STD 8.3 6 5.3 11.6 6 4.7 , 0.001 5.8 6 2.5 7.2 6 2.3 , 0.001 8.0 6 4.8 9.3 6 4.8 0.048
Maximum STD (mm) 2.5 6 1.0 2.2 6 1.1 0.01 2.3 6 1.0 2.2 6 1.0 0.9 1.5 6 0.5 1.3 6 0.6 0.1
Positive ECG leads (n) 6.6 6 0.9 5.9 6 2.2 0.2 5.4 6 1.8 5.5 6 1.6 0.8 4.3 6 2.1 3.4 6 1.9 0.08
Total peak STD (mm) 13.6 6 5.6 11.2 6 6.7 0.006 10.1 6 5.8 10.2 6 6.2 0.9 5.8 6 3.4 4.6 6 2.5 0.08
Recovery time (min) 5.7 6 3.5 2.7 6 2.0 0.002 3.9 6 3.4 2.3 6 2.4 0.004 3.0 6 2.9 0.9 6 0.4 0.04
Data presented as mean value 6 SD. Ex 5 exercise; METS 5 metabolic equivalents; RPP 5 rate–pressure product; min 5 minutes; STD 5 ST-segment depression.
Figure 2. Maximum (Max) STD
equivalent in millimeters plotted for
each subject in whom it could be
measured in exercises (Ex) 1 and 2 in
the three study groups. See text for
definition of this parameter. Vertical
bars display means and SDs.
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(1.10 6 0.10 vs. 1.15 6 0.15, respectively; p 5 NS). However,
with the more intense protocol, wall motion score indexes at
baselines 1 and 2 were significantly different, with persistent
contractile dysfunction at baseline 2 (1.10 6 0.07 vs. 1.20 6
0.15, respectively; p 5 0.045). This supports the original
analysis that the more intense exercise protocol was responsi-
ble for the persistent wall motion abnormality prior to reexer-
cise.
Role of adrenergic tone. To determine whether there might
be a relation between the degree of attenuation of ischemia on
re-exercise and the increased resting RPP prior to exercise 2
compared with the resting RPP prior to exercise 1, the change
in this latter parameter (considered an index of adrenergic
tone) was correlated to the change in ischemic threshold and to
the change in the maximum STD equivalent. No relation was
found.
Discussion
This study confirms and extensively characterizes, with
exercise ECG and contractile function data, the impressive
attenuation of exercise-induced myocardial ischemia that has
been observed with repeated exercise (2,3,5,7–10). In addition,
its principal findings are that: 1) this phenomenon appears to
be independent of the intensity of the exercise protocol; 2) the
attenuation of myocardial ischemia is not explained by a
down-regulation of cardiac contractile function induced by the
initial ischemic stimulus; 3) this phenomenon does not appear
to be mediated by a K1-ATP dependent mechanism; and 4) it
is not related to adrenergic tone.
Exercise ECG data. Exercise duration, workload achieved
and maximum RPP increased significantly on re-exercise.
These improvements were not necessarily due to an attenua-
tion of myocardial ischemia and may have been the conse-
quence of a training or learning effect. However, all subjects
were already very familiar with treadmill exercise and had
previously passed several reproducible ETs. Moreover, the
resting RPP prior to ET 2 was consistently higher than it was
prior to ET 1, arguing against the presence of a training effect.
Time to angina increased significantly on re-exercise but this
variable is subjective. Time to 1-mm STD also increased
significantly but might be due to improved hemodynamic
conditions on re-exercise rather than to a change in the
ischemic threshold. Maximum and total STD and the number
of positive leads at peak exercise would not be expected to
undergo much modification on re-exercise because subjects
performed to a similar symptom-limited end point. Although
postexercise STD recovery time was substantially reduced
following the second exercise, it is not established as an index
of ongoing myocardial ischemia and probably reflects the
intensity of exercise-induced ischemia (15,16). However, two
quantifiable exercise ECG indicators of myocardial ischemia
did markedly improve on re-exercise. First, the RPP at the
onset of 1-mm STD, which is considered a valid and relatively
constant index of the ischemic threshold (17–19), was almost
20% higher on re-exercise and an increase in the ischemic
threshold was observed in over 80% of subjects, as has been
found in other studies (7–10). Second, we analyzed a novel
parameter that highlights even more strikingly the blunting of
ischemia on reexercise. The maximum STD equivalent or STD
at ET 2 corresponding to the maximum RPP of ET 1 was less
than half the value of maximum STD in ET 1. A decrease in
this parameter was observed in over 90% of subjects in whom
it could be measured.
Relation to exercise protocol. This study tested whether the
intensity of exercise might affect the degree of attenuation of
myocardial ischemia on re-exercise. The very gradual standard
Naughton protocol might have simply provided an ongoing
warm-up or conditioning stimulus so that, on re-exercise, little
or no further attenuation of ischemia might be observed.
However, the findings for group I show that this was not the
case. On the other hand, a more intensive exercise protocol
with a halving of the stages to 1 min might have provided a
Figure 3. Echocardiographic LV wall motion score indexes (means
and SDs) at baselines (Rest) and immediately following each exericse
(Ex) in groups I and II.
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stronger conditioning stimulus, creating a greater attenuation
of ischemia on re-exercise. Alternatively, by allowing less time
for achieving steady states during initial exercise, such a
protocol might have been less propitious for the blunting of
ischemia on reexercise. However, the results indicate that the
degree of attenuation of myocardial ischemia is similar regard-
less of the intensity of the ischemic primer or of ET 2.
Relation to contractile function and the down-regulation
hypothesis. Both exercise protocols similarly showed that LV
contractile function on ET 2 compared with its baseline was
significantly less perturbed than on ET 1, a finding consistent
with the attenuation of symptoms and ECG signs of ischemia.
To our knowledge, this is the first study to evaluate the
relation of cardiac contractility to the attenuation of myocar-
dial ischemia observed with re-exercise and to determine
whether an ischemia-induced down-regulation or stunning of
contractile function rematching oxygen supply and demand
could account for the attenuation of ischemia. This hypothesis
has been evoked but not directly tested (4,12,13). Okazaki et
al. (6) cannulated the great cardiac vein in IHD subjects with
isolated significant anterior descending artery stenosis to mea-
sure regional coronary flow by thermodilution and also mea-
sured oxygen consumption and locally released adenosine
while subjects performed two supine ergometric ETs. Al-
though STD occurred later and was attenuated on ET 2,
coronary flow did not increase in the ischemic zone. There was
also less myocardial oxygen consumption and greater adeno-
sine release in this zone on ET 2. A decrease in contractile
function as a result of ET 1 could have accounted for these
observations, but the authors did not evaluate this and believed
that it was not the responsible mechanism because baseline
oxygen consumption before the two tests was similar. However,
this observation per se does not rule out a myocardial stunning
mechanism (20). Williams et al. (4) subjected IHD patients to
two sequential rapid atrial pacings and documented less isch-
emia during the second pacing as measured by angina, STD
and lactate extraction but found comparable coronary flow
(similarly using great cardiac vein cannulation and thermodi-
lution) and reduced myocardial oxygen consumption on the
second pacing. They suggested that the mechanism was a
reduction in regional myocardial contractility although this
parameter was not evaluated. The possibility of diminished
contractile function also was suggested by the work of Thadani
et al. (12), who observed a decrease in cardiac output on the
second of two rapid cardiac pacings in angina subjects.
The findings from exercise protocol I in the present study
appear to exclude ischemia-induced down-regulation of con-
tractile function as the mechanism accounting for the attenu-
ation of ischemia observed with repeated exercise. In the 12
subjects studied with echocardiography in protocol I, LV wall
motion returned to the initial baseline (which was normal in
most cases) prior to ET 2 in all but two subjects. However, this
was not so with the more intense exercise protocol II. Signif-
icant wall motion abnormality persisted prior to ET 2. In this
case, down-regulation of contractile function could account for
some or all of the attenuation of ECG ischemic parameters
and ischemia-induced contractile dysfunction observed with
ET 2. By restudying eight patients with cross-over to the other
exercise protocol, we determined that it was the intensity of
exercise that accounted for the persistent LV dysfunction prior
to ET 2. Thus, the findings of exercise protocol I indicate that
down-regulation of contractile function cannot explain the
attenuation of ischemia observed with re-exercise, although
the findings of exercise protocol II do not rule out the
contribution of such a mechanism when exercise is more
intense. However, if down-regulation or stunning were a
contributory mechanism, it might have been expected to result
in a greater attenuation of ECG ischemia in protocol II than
that observed in protocol I where down-regulation was not
observed. Because the degree of ECG ischemic attenuation
was similar when the two protocols are compared, it is unlikely
that down-regulation or stunning contributes in any significant
way to this phenomenon.
It has been suggested that the attenuation of ischemia with
repeated exercise is a form of ischemic preconditioning,
whereby myocardium subjected to brief coronary artery occlu-
sions becomes conditioned to better withstand subsequent
more severe ischemia (4,6–9,21). Our findings are also consis-
tent with experimental data dissociating stunning and classic
ischemic preconditioning (22–24).
Relation to K1-ATP. Activation of sarcolemmal and mito-
chondrial K1-ATP in cardiac myocytes is implicated in isch-
emic preconditioning, and the latter can be inhibited with
blockade of K1-ATP using the oral hypoglycemic agent glib-
enclamide (25–29). Therefore, diabetic angina subjects taking
robust chronic daily doses of glibenclamide constitute a model
to test whether the attenuation of ischemia with repeated
exercise may also be attributable to a metabolic mechanism via
activation of myocardial K1-ATP. Therapeutic concentrations
of glibenclamide have been shown to block vascular K1-ATP
in humans (30). However, we found that the degree of
attenuation of myocardial ischemia on reexercise was similar in
diabetic subjects on glibenclamide and in nondiabetic subjects,
suggesting that K1-ATP activation is not the underlying mech-
anism. This conclusion must be tempered by two caveats: 1)
clinical doses of glibenclamide might be insufficient to block
K1-ATP in cardiac myocytes effectively and 2) when gliben-
clamide is used long term, the presence of endogenous coun-
tervailing or escape mechanisms from K1-ATP blockade can-
not be excluded. However, our findings are in agreement with
a recent study in which no modification was found in the
degree of attenuation of myocardial ischemia on reexercise
when nondiabetic subjects received 10 mg oral glibenclamide
acutely (31). The ischemic threshold was not evaluated in the
latter study.
Potential limitations. We compared two exercise protocols
but initially used different subjects in each protocol. We also
compared diabetic subjects taking glibenclamide with nondia-
betic subjects not taking glibenclamide. The findings might
appear less strong than if subjects had served as their own
controls. However, this is unlikely because findings were
consistent in direction and magnitude across the three study
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groups, which were comparable in age (except for the older
diabetic subjects), gender, degree of coronary artery disease
and LV function. In addition, subsequent cross-over data in
eight subjects confirmed our initial observations. Finally, these
results obtained in subjects with conserved LV function might
not necessarily be reproducible in the presence of prior large
myocardial infarction.
Conclusions. This study confirms and systematically char-
acterizes the impressive attenuation of myocardial ischemia
observed with repeated exercise. Our results suggest that this
attenuation is unexplained by stunning or contractile down-
regulation, adrenergic tone or K1-ATP activation. Future
work should attempt to identify this intriguing endogenous
mechanism.
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